These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Perfluorocarbon compound aerosols for delivery to the lung as potential 19F magnetic resonance reporters of regional pulmonary pO2. Thomas SR; Gradon L; Pratsinis SE; Pratt RG; Fotou GP; McGoron AJ; Podgorski AL; Millard RW Invest Radiol; 1997 Jan; 32(1):29-38. PubMed ID: 9007645 [TBL] [Abstract][Full Text] [Related]
23. PFC@O Lan Z; Zou KL; Cui H; Chen H; Zhao YY; Yu GT J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675491 [TBL] [Abstract][Full Text] [Related]
24. The intravenous perfluorocarbon emulsion Oxycyte does not increase hyperbaric oxygen-related seizures in a non-sedated swine model. Mahon RT; Hall A; Bodo M; Auker C Eur J Appl Physiol; 2013 Nov; 113(11):2795-802. PubMed ID: 24062008 [TBL] [Abstract][Full Text] [Related]
25. Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: a Theranostic for Acute Stroke. Deuchar GA; van Kralingen JC; Work LM; Santosh C; Muir KW; McCabe C; Macrae IM Transl Stroke Res; 2019 Oct; 10(5):583-595. PubMed ID: 30506268 [TBL] [Abstract][Full Text] [Related]
26. A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief. Jiang M; Qin B; Luo L; Li X; Shi Y; Zhang J; Luo Z; Zhu C; Guan G; Du Y; You J J Control Release; 2021 Jul; 335():408-419. PubMed ID: 34089792 [TBL] [Abstract][Full Text] [Related]
27. Hemoglobin-mediated biomimetic synthesis of paramagnetic O Shi X; Yang W; Ma Q; Lu Y; Xu Y; Bian K; Liu F; Shi C; Wang H; Shi Y; Zhang B Theranostics; 2020; 10(25):11607-11621. PubMed ID: 33052236 [TBL] [Abstract][Full Text] [Related]
28. Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation. Dou Y; Liu Y; Zhao F; Guo Y; Li X; Wu M; Chang J; Yu C Theranostics; 2018; 8(21):5870-5889. PubMed ID: 30613268 [TBL] [Abstract][Full Text] [Related]
30. Chemical Modulation of Glucose Metabolism with a Fluorinated CaCO Dong Z; Wang C; Gong Y; Zhang Y; Fan Q; Hao Y; Li Q; Wu Y; Zhong X; Yang K; Feng L; Liu Z ACS Nano; 2022 Sep; 16(9):13884-13899. PubMed ID: 36075132 [TBL] [Abstract][Full Text] [Related]
31. Perfluorocarbon@Porphyrin Nanoparticles for Tumor Hypoxia Relief to Enhance Photodynamic Therapy against Liver Metastasis of Colon Cancer. Liang X; Chen M; Bhattarai P; Hameed S; Dai Z ACS Nano; 2020 Oct; 14(10):13569-13583. PubMed ID: 32915537 [TBL] [Abstract][Full Text] [Related]
35. Perfluorocarbon Enhanced Glasgow Oxygen Level Dependent (GOLD) Magnetic Resonance Metabolic Imaging Identifies the Penumbra Following Acute Ischemic Stroke. Deuchar GA; Brennan D; Holmes WM; Shaw M; Macrae IM; Santosh C Theranostics; 2018; 8(6):1706-1722. PubMed ID: 29556351 [TBL] [Abstract][Full Text] [Related]
36. Resuscitation of severe but brief haemorrhagic shock with PFC in rabbits restores skeletal muscle oxygen delivery and does not alter skeletal muscle metabolism. Audonnet-Blaise S; Krafft MP; Smani Y; Mertes PM; Marie PY; Labrude P; Longrois D; Menu P Resuscitation; 2006 Jul; 70(1):124-32. PubMed ID: 16759782 [TBL] [Abstract][Full Text] [Related]
37. Tumor reoxygenation for enhanced combination of radiation therapy and microwave thermal therapy using oxygen generation in situ by CuO nanosuperparticles under microwave irradiation. Chen Z; Guo W; Wu Q; Tan L; Ma T; Fu C; Yu J; Ren X; Wang J; Liang P; Meng X Theranostics; 2020; 10(10):4659-4675. PubMed ID: 32292521 [TBL] [Abstract][Full Text] [Related]
38. Glutathione depletion and dual-model oxygen balance disruption for photodynamic therapy enhancement. Li W; Yong J; Xu Y; Wang Y; Zhang Y; Ren H; Li X Colloids Surf B Biointerfaces; 2019 Nov; 183():110453. PubMed ID: 31465940 [TBL] [Abstract][Full Text] [Related]
39. An Oxygen Self-sufficient Fluorinated Nanoplatform for Relieved Tumor Hypoxia and Enhanced Photodynamic Therapy of Cancers. Ma S; Zhou J; Zhang Y; Yang B; He Y; Tian C; Xu X; Gu Z ACS Appl Mater Interfaces; 2019 Feb; 11(8):7731-7742. PubMed ID: 30694643 [TBL] [Abstract][Full Text] [Related]
40. Overcoming chemotherapy resistance using pH-sensitive hollow MnO Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]